<?xml version="1.0" encoding="utf-8"?>
<publicwhip>

<spmotion spid="S1M-1676" date="2001-02-16" filename="day-bb-01_bb-02-16f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-02-16f.htm">
*S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. 
</spmotion>

<spmotion spid="S1M-1676" date="2001-02-26" filename="day-bb-01_bb-02-26f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-02-26f.htm">
 S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell*, Mr Kenneth Gibson*, Christine Grahame*, Dorothy-Grace Elder* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-02-27" filename="day-bb-01_bb-02-27f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-02-27f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Donald Gorrie*, Shona Robison* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-02-28" filename="day-bb-01_bb-02-28f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-02-28f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Alex Neil*, Mr Adam Ingram*, Mrs Margaret Ewing*, Michael Matheson*, Mr Lloyd Quinan*, Robin Harper* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-01" filename="day-bb-01_bb-03-01f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-01f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Ms Sandra White*, Fiona McLeod* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-02" filename="day-bb-01_bb-03-02f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-02f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Mr Alex Salmond* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-05" filename="day-bb-01_bb-03-05f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-05f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-06" filename="day-bb-01_bb-03-06f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-06f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Fergus Ewing* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-07" filename="day-bb-01_bb-03-07f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-07f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Linda Fabiani*, Fiona Hyslop* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-08" filename="day-bb-01_bb-03-08f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-08f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Mr Kenny MacAskill*, Tricia Marwick*, Andrew Wilson*, Mr Duncan Hamilton* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-12" filename="day-bb-01_bb-03-12f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-12f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond, Fergus Ewing, Linda Fabiani, Fiona Hyslop, Mr Kenny MacAskill, Tricia Marwick, Andrew Wilson, Mr Duncan Hamilton 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-14" filename="day-bb-01_bb-03-14f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-14f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Colin Campbell* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-19" filename="day-bb-01_bb-03-19f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-19f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond, Fergus Ewing, Linda Fabiani, Fiona Hyslop, Mr Kenny MacAskill, Tricia Marwick, Andrew Wilson, Mr Duncan Hamilton, Colin Campbell 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-20" filename="day-bb-01_bb-03-20f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-20f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Kay Ullrich* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-26" filename="day-bb-01_bb-03-26f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-26f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond, Fergus Ewing, Linda Fabiani, Fiona Hyslop, Mr Kenny MacAskill, Tricia Marwick, Andrew Wilson, Mr Duncan Hamilton, Colin Campbell, Kay Ullrich 
</spmotion>

<spmotion spid="S1M-1676" date="2001-03-27" filename="day-bb-01_bb-03-27f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-27f.htm">
 S1M-1676# Treatment for Alzheimer's Sufferers (lodged on 15 February 2001) Tommy Sheridan* 
</spmotion>

<spmotion spid="S1M-1676" date="2001-04-02" filename="day-bb-01_bb-04-02f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-04-02f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond, Fergus Ewing, Linda Fabiani, Fiona Hyslop, Mr Kenny MacAskill, Tricia Marwick, Andrew Wilson, Mr Duncan Hamilton, Colin Campbell, Kay Ullrich, Tommy Sheridan 
</spmotion>

<spmotion spid="S1M-1676" date="2001-04-23" filename="day-bb-01_bb-04-23f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-04-23f.htm">
S1M-1676# Richard Lochhead: Treatment for Alzheimer's Sufferers—That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients. Supported by: Michael Russell, Mr Kenneth Gibson, Christine Grahame, Dorothy-Grace Elder, Donald Gorrie, Shona Robison, Alex Neil, Mr Adam Ingram, Mrs Margaret Ewing, Michael Matheson, Mr Lloyd Quinan, Robin Harper, Ms Sandra White, Fiona McLeod, Mr Alex Salmond, Fergus Ewing, Linda Fabiani, Fiona Hyslop, Mr Kenny MacAskill, Tricia Marwick, Andrew Wilson, Mr Duncan Hamilton, Colin Campbell, Kay Ullrich, Tommy Sheridan 
</spmotion>

</publicwhip>
